CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-07-24). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 1755 · Search date 2026-07-24 · Methodology v0.6

Monopolar radiofrequency,
does it really help with Improvement in the appearance of facial laxity and wrinkles?

30-Second Summary
C
Evidence Grade C · 42 · Safety caution
Monopolar RF matched a standard RF device, but how much it beats no treatment remains uncertain
What the
research shows
Monopolar radiofrequency is rated C because noninferiority to another active device was shown, but net benefit versus sham was not. Wang 2026, Lasers Med Sci 41(1):39, was an active-control noninferiority comparison of YOUMAGIC versus Thermage CPT. GAIS was 100% versus 98.1%, with superiority P=.24. There was no sham or untreated control, and the device manufacturer, a WE Medical Technology affiliate, was involved, supporting C with 42 points.
What the
ads claim
Marketing converts similarity to another RF device into certain lifting versus no treatment and surgical-grade wrinkle removal. Noninferiority does not mean that an intervention defeated a no-effect control.
*

Useful facts when choosing a product

  • Monopolar RF current heats the dermis through tissue resistance while cooling the surface, aiming to induce collagen contraction and remodeling.
  • Results vary, are assessed over months after one treatment, and are not equivalent to a surgical facelift.
  • Pain, erythema, edema, mild thermal burns, and rare fat atrophy or contour irregularity can occur.
Gap Measurement · Verdict 1755 · C 42
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Wang 2026, Lasers Med Sci 41(1):39, randomized 212 participants to YOUMAGIC, 107, or Thermage CPT, 105, in an active-control noninferiority design. Ninety-day GAIS was 100% versus 98.1%; noninferiority within the prespecified -10% margin succeeded, but superiority was null at P=.24. There was no sham or untreated control, and the device manufacturer, a WE Medical Technology affiliate, was involved through device provision. For comparison, verdict 1754, which is C with 45 points, concerns HIFU or MFU, a different ultrasound device.

02

Why this is classified as C (42)

The prespecified primary noninferiority endpoint succeeded in the 212-person full-analysis set, but this was not net benefit versus sham. Subjective GAIS, retrospective registration, manufacturer device provision, and absent independent sham replication give C with 42 points.

Counterpoint. The trial suggests short-term appearance results similar to a standard RF device, but absolute effect size and clinical meaning require sham-controlled evidence.

Rejudgment record. Cross-check applied — YOUMAGIC versus Thermage CPT active-control noninferiority succeeded, but superiority was null at P=.24, no sham or untreated control existed, and a WE Medical Technology affiliate was involved, invoking rule ①-ⓒ

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Improved facial-wrinkle appearance at 90 daysCNoninferiority to active RF succeeded, but net benefit versus sham is unknown.
Facial skin tighteningCA signal similar to another device exists, but evidence centers on subjective ratings and manufacturer-supplied equipment.
Maintenance of appearance improvement for six monthsCActive-control follow-up suggests persistence, but independent sham replication is absent.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Wang Z et al. 2026Multicenter randomized assessor-blind active-control noninferiority trial212YOUMAGIC devices supplied by WE Medical Technology Co., Ltd.Primary: noninferiority within a -10% margin for blinded 90-day GAIS facial-wrinkle responseNoninferiority succeeded; 100% versus 98.10%, superiority P=.24, with the 95% CI meeting the -10% margin.Pivotal large active-control trial
Wang Z et al. 2025Prospective randomized active-control trial40No external funding reported; comparison of the novel YOUMAGIC device with ThermageSix-month appearance and nasolabial-fold volume changes without a sham controlBoth devices improved from baseline, but between-device volume differences were null.Small supportive active-control evidence
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-07-24).

Wang Z, Li T, Wa Q, Liu Z, Yang B, Yan Y. Efficacy and safety of a novel monopolar radiofrequency device for skin tightening: a multicenter, randomized, 6-month, assessor blind, positive parallel-controlled, non-inferiority trial. Lasers Med Sci. 2026;41(1):39. PMID: 41758257. PMCID: PMC12948897. DOI: 10.1007/s10103-026-04841-4.
checked
Wang Z, Li L, Zhang X, Li Z, Yan Y. Long-Term Efficacy and Safety of a Novel Monopolar Radiofrequency Device for Skin Tightening: A Prospective Randomized Controlled Study. Lasers Surg Med. 2025;57(3):259-264. DOI: 10.1002/lsm.70002.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-24 · Corrections: none

Cite this verdict

Monopolar radiofrequency x facial laxity and wrinkle appearance Evidence Grade C card
[Chamgap] Monopolar radiofrequency x facial laxity and wrinkle appearance — Evidence Grade C·42. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/skin-hair/monopolar-radiofrequency-facial-laxity-wrinkles/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.